Research programme: herpes simplex virus vaccine - AlphaVaxAlternative Names: HSV alphavaccine - AlphaVax; HSV vaccine - AlphaVax
Latest Information Update: 10 Sep 2015
At a glance
- Originator AlphaVax
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes simplex virus infections
Most Recent Events
- 10 Sep 2015 Preclinical development is ongoing in USA
- 29 May 2009 Preclinical trials in Herpes simplex virus infections in USA (Parenteral)